Acute necrotizing myopathy of intensive care: Electrophysiological studies
- 1 March 1994
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 17 (3) , 285-292
- https://doi.org/10.1002/mus.880170305
Abstract
A series of recent reports have identified cases of a quadriplegic myopathy characterized by myofiber necrosis and loss of myosin filaments associated with the use of nondepolarizing muscle blocking agents and glucocorticoids. We report electrophysiological findings in 7 intensive care unit patients who developed evidence of an acute myopathy in association with the use of nondepolarizing muscle blocking agents. Several important features were identified: (i) a neuromuscular transmission deficit was observed in 3 patients up to 7 days following withdrawal of vecuronium; (ii) motor M potentials were of low amplitude, there was mild abnormal spontaneous activity on needle electromyography, and sensory conduction was relatively preserved; (iii) not all patients received glucocorticoids or were asthmatic; (iv) 2 patients given vecuronium had very high creatine kinase levels and developed acute renal failure associated with myoglobinuria; and (v) rises in motor M potentials accompanied clinical recovery. This complication of intensive care may be severe, but is reversible and possibly avoidable. Our findings implicate nondepolarizing muscle blocking agents in the development of the myopathy. Electrophysiological studies provide important prognostic guidance. © 1994 John Wiley & Sons, Inc.Keywords
This publication has 18 references indexed in Scilit:
- Acute myopathy and neuropathy in status asthmaticus: Case report and literature reviewMuscle & Nerve, 1993
- Acute quadriplegic myopathyNeurology, 1992
- Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervationMuscle & Nerve, 1992
- Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatmentMuscle & Nerve, 1991
- Prolonged paralysis after treatment with neuromuscular junction blocking agentsCritical Care Medicine, 1991
- S THE INDEPENDENT MEASUREMENT OF 3-DESACETYLVECU RONIUM INFLUENCE THE PHARMACOKINETICS OF VECURONIUM?Anesthesiology, 1988
- Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilationClinical Neurology and Neurosurgery, 1985
- Polyneuropathy in critically ill patients.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Vecuronium: A New Nondepolarizing Neuromuscular‐Blocking Agent; Clinical Pharmacology, Pharmacokinetics, Cardiovascular Effects and Use in Special Clinical SituationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- NEUROMUSCULAR AND VAGAL BLOCKING ACTIONS OF PANCURONIUM BROMIDE, ITS METABOLITES, AND VECURONIUM BROMIDE (ORG NC 45)AND ITS POTENTIAL METABOLITES IN THE ANAESTHETIZED CATBritish Journal of Anaesthesia, 1983